Collaboration with Healthcare Professionals and Healthcare Organizations

Collaboration between healthcare professionals, healthcare organizations, and the pharmaceutical industry is crucial for enhancing patient care and advancing research and development. Whether it's partnering on research for new medications or exploring treatment options, these interactions foster innovative thinking and lead to the development of better medicines.

Daiichi Sankyo is fully committed to transparency regarding financial relationships between physicians, teaching hospitals, and the pharmaceutical industry. We adhere to the principles of the Physician Payments Sunshine Act and the Open Payments Guidelines, ensuring full compliance with the law. We believe that these disclosures promote a broader understanding of how these essential relationships contribute to our ability to develop life-saving medications and meet patient needs.

To view the information Daiichi Sankyo, Inc. reports to the US Center for Medicare and Medicaid Services (CMS) in accordance with the Sunshine Act provisions of the Affordable Care Act, please visit the CMS Open Payments website.